Akademisyen
ENRICO BORRELLI
DOKTOR (Kısmi Zamanlı, Yurt Dışı)
BİRUNİ ÜNİVERSİTESİ TIP FAKÜLTESİ CERRAHİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Göz Hastalıkları
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 33
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
26
Q2
7
Q3
0
Q4
0
WoS (JCR)
Q1
17
Q2
9
Q3
7
Q4
0
TR Index
0
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
17
Ort. yüzdelik
87.5%
Üst %1 payı
0.0%
Üst %10 payı
51.5%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Choriocapillaris flow in two different patterns of exudative type 1 macular neovascularization YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.6%
- 2024 Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.1%
- 2024 Structural OCT and OCT angiography biomarkers associated with the development and progression of geographic atrophy in AMD YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 98.1%
- 2024 Optical coherence tomography biomarkers indicating visual enhancement in diabetic macular edema resolved through anti-VEGF therapy YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 98.1%
- 2024 OCT risk factors for 2-year foveal involvement in non-treated eyes with extrafoveal geographic atrophy and AMD YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 96.5%
- 2024 Sectorial Ganglion Cell Complex Thickness as Biomarker of Vision Outcome in Patients With Dominant Optic Atrophy YÖKSİS SJR Q1 JCR Q1 OpenAlex 77.2%
- 2024 Validation of a deep learning model for automatic detection and quantification of five OCT critical retinal features associated with neovascular age-related macular degeneration YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.7%
- 2024 Comparative Study on Anti-VEGF in Wet Age-Related Macular Degeneration in the Setting Based on Lean Methodology from the Bari Intravitreal Injection Registry (BIVIR) YÖKSİS SJR Q1 JCR Q1 OpenAlex 76.1%
- 2024 Choroidal remodeling following different anti-VEGF therapies in neovascular AMD YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.8%
- 2024 Pitchfork sign following pars Plana vitrectomy for idiopathic epiretinal membrane: A case report YÖKSİS SJR Q2 JCR Q3 OpenAlex 49.9%
- 2024 Distinct Pathways of Macular Atrophy in Type 3 Macular Neovascularization Associated With AMD YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.4%
- 2024 Mitochondrial retinopathies and optic neuropathies: The impact of retinal imaging on modern understanding of pathogenesis, diagnosis, and management YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 93.0%
- 2024 Platelet concentrates in macular hole surgery. A journey through the labyrinth of terminology, preparation, and application: a comprehensive review YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 92.2%
- 2024 Relationship of Topographic Distribution of Macular Atrophy Secondary to Neovascular AMD and Reading Performance YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.5%
- 2024 Platelet rich plasma for primary macular hole: A case series YÖKSİS SJR Q2 JCR Q3 OpenAlex 73.6%
- 2024 Retinal OCT biomarkers associated with reading performance in patients with persistent vs. resolved diabetic macular edema YÖKSİS SJR Q2 JCR Q3 OpenAlex 76.3%
- 2023 Capturing the Transition From Intermediate to Neovascular AMD: Longitudinal Inner Retinal Thinning and Factors Associated With Neuronal Loss YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.9%
- 2023 Choriocapillaris Reperfusion in Resolved Chronic Central Serous Chorioretinopathy Treated with Eplerenone: Long-Term Effects on the Fellow Eye YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 94.1%
- 2023 Imaging Biomarkers of Mesopic and Dark-Adapted Macular Functions in Eyes With Treatment-Naïve Mild Diabetic Retinopathy YÖKSİS SJR Q1 JCR Q1 OpenAlex 83.8%
- 2023 Prevalence and Morphologic Biomarkers of Metamorphopsia in eyes with “Resolved” Chronic Central Serous Chorioretinopathy YÖKSİS SJR Q1 JCR Q2 OpenAlex 82.2%